Navigation Links
Genaera to Present at Therapeutic Area Partnerships 2008
Date:10/30/2008

-Nominated as One of the Top 10 Most Interesting Metabolic Projects Available for Partnering-

PLYMOUTH MEETING, Pa., Oct. 30 /PRNewswire-FirstCall/ -- Genaera Corporation (NASDAQ: GENR) will present at the Windhover's Therapeutic Area Partnerships Conference being held November 3-5 at the Lowes Hotel in Philadelphia, Pennsylvania. Dr. Henry Wolfe, Executive Vice President and Chief Scientific Officer, will provide an overview on MSI-1436 for the treatment of type 2 diabetes and obesity on Tuesday, November 4, 2008 at 4:20 p.m. (ET).

About Genaera

Genaera Corporation is developing trodusquemine (MSI-1436), for type 2 diabetes and obesity currently in phase 1 clinical testing and has a fully out-licensed partnership with MedImmune, Inc. that is in phase 2 clinical testing in asthma. For further information, please see our website at http://www.genaera.com.

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, known and unknown. Forward-looking statements reflect management's current views and are based on certain expectations and assumptions. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "believe," "continue," "develop," "expect," "plan" and "potential" or other words of similar meaning. Genaera's actual results and performance could differ materially from those currently anticipated and expressed in these and other forward-looking statements as a result of a number of risk factors, including, but not limited to the risks and uncertainties discussed in Genaera's filings
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Genaera Receives Non-Compliance Notice From NASDAQ
2. Genaera Corporations 2008 Annual Stockholder Meeting Results
3. Xmark Comments on Genaera Cost-Saving Plan
4. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
5. Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
6. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
7. Abbott to Present at 17th Annual Credit Suisse Health Care Conference
8. Derma Sciences to Present at The Rodman & Renshaw 10th Annual Healthcare Conference
9. CPC Appoints Medical Product Service GmbH as Authorized European Representative for MedClose(TM) System
10. Wound Management Technologies, Inc. Announces Strategic Business Directions, Recent Conference Presentation, in Addition to Symposium Exhibit Plans for Las Vegas
11. Cantel Medical Corp. to Present at the Oppenheimer & Co. 19th Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... , "This bill provides for an unprecedented ...alth care about if it is not for preserving and pr...t must be defeated." Charmaine Yoest ,, WASH...ns United for Life Action President and CEO Dr. Ch...enate by releasing the following statement: ,,...
(Date:11/21/2009)... NH based medical credentialing ... its industry to form a partnerhsip with Amerinet,...This partnership will help to transform quality ca... (Vocus) November 21, 2009 -- ISG Group, ...unced a new agreement with Amerinet Inc., a leadin...
(Date:11/21/2009)... Linwood Group ask whether there... be measured? , London, U...l that with up to one in three of the adult UK pop...f developing alcohol-related liver disease*, it is...ing to rehabilitation programmes and residential c...
(Date:11/20/2009)..., QUINCY, Mass., Nov. 20 Followi...arket Company removed from sale Shedd,s Country Cr...e and Shedd,s Country Crock ® Side Dishes DEL... allergen. ,, The following code dates and UPC...; Side Dishes DELUXE Cheddar Broccoli Rice 21 oz, ...
(Date:11/20/2009)... , HAIFA, Israel, November 20 /PRNewswire-... (CVSL.OB), http://www.CVSLMEDICAL.COM , a leadin...hnology, today announced that,the company,s Board ...ations,in Europe, Canada and the Far East for its ...applicable for all angioplasty (PCTA) procedures. ...
Breaking Medicine News(10 mins):Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
...ches new version of Infection Surveillance and Con...ONTO, Oct. 18 /PRNewswire/ - rL Solutions, the lea...tware, today announced the release of,Infection Mo...PW), running from October,14th to the 20th, is ent...
...Global Med Technologies(R),Inc. (OTC Bulletin Boar...mation technology company, announced today that it...as submitted its ElDorado Donor(TM),software for a...e FDA. ElDorado Donor is intended as a comprehens...
...Many people, including significant proportions of ...r from post-traumatic stress disorder (PTSD), ofte... While several drugs and psychotherapies are used...hat doesn,t, says a new report from the Institute ...
... N.J. A revolutionary, new biomaterial, developed... at Rutgers University, has moved from the lab ben...nt, a product of a breakthrough methodology in bio...ts are tiny tubes inserted into diseased arteries ...
...eveals heightened activity of neurotransmitter dop...s) -- Researchers have identified molecular mechan... are less vulnerable to the stress caused by diffi...he post-traumatic stress disorder suffered by troo...
...n. -- Mayo Clinic has clarified the methods of dia...-understood blood vessel disease of the brain and ...rimary central nervous system vasculitis (PCNSV) c... laboratory studies. , This disease is often susp...
Other Medicine News:Health News:Infection MonitorPro Version 1.1 Released during International Infection Prevention Week 2Health News:Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA 2Health News:Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA 3Health News:Effectiveness of most PTSD therapies is uncertain 2Health News:Effectiveness of most PTSD therapies is uncertain 3Health News:Rutgers biomaterial debuts in clinical trials of new stent 2Health News:Rutgers biomaterial debuts in clinical trials of new stent 3Health News:Vulnerability to Stress Linked to Brain Molecule 2Health News:Vulnerability to Stress Linked to Brain Molecule 3Health News:Mayo Clinic clarifies diagnosis for serious blood vessel disease of brain and spinal cord 2Health News:Mayo Clinic clarifies diagnosis for serious blood vessel disease of brain and spinal cord 3
(Date:11/19/2009)..., BIRMINGHAM, Ala., Nov. 19 /PRNewswire-FirstCall/...) today announced the pricing of a public offering...per share, resulting in gross proceeds of $48.75 m...oCryst pursuant to an effective shelf registration...d Exchange Commission. BioCryst has also granted ...
(Date:11/19/2009)...AYTON, Ohio, Nov. 19 Riverain Medi...ering with leading Canadian medical imaging distri...est Imaging and OnGuard Chest Xray CAD. The exclus...in Medical,s products to the Canadian market throu...s channel. ,, SoftView Enhanced Chest Imaging i...
(Date:11/19/2009)..., SCHAUMBERG, Ill., Nov. 19 Mach...CS-neutral healthcare image management solutions, ... provide a combined PACS- neutral archive solution...a Distributing, an international leader in providi...ons to the medical industry. Under the agreement,...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4WebMD to Present at Jefferies 3rd Annual Healthcare Conference 48792 1Individuals Who Apply Pesticides Are Found to Have Double the Risk of Blood Disorder 48790 1Individuals Who Apply Pesticides Are Found to Have Double the Risk of Blood Disorder 48790 2Individuals Who Apply Pesticides Are Found to Have Double the Risk of Blood Disorder 48790 3Individuals Who Apply Pesticides Are Found to Have Double the Risk of Blood Disorder 48790 4Acoustiblok Inc Combines Sound Abatement and Insulation Materials at Broward County Waste to Energy Plant to Reduce Industrial Noise Pollution 48788 1Acoustiblok Inc Combines Sound Abatement and Insulation Materials at Broward County Waste to Energy Plant to Reduce Industrial Noise Pollution 48788 2Acoustiblok Inc Combines Sound Abatement and Insulation Materials at Broward County Waste to Energy Plant to Reduce Industrial Noise Pollution 48788 3Acoustiblok Inc Combines Sound Abatement and Insulation Materials at Broward County Waste to Energy Plant to Reduce Industrial Noise Pollution 48788 4Acoustiblok Inc Combines Sound Abatement and Insulation Materials at Broward County Waste to Energy Plant to Reduce Industrial Noise Pollution 48788 5
...tely-held,specialty pharmaceutical company, announ...sponsored by its wholly owned subsidiary, Innocoll...MICIN SURGICAL IMPLANT for,the prevention of surgi...MICIN SURGICAL IMPLANT is a fully biodegradable, l...broad spectrum aminoglycoside,antibiotic, gentamic...
...s of testosterone, we usually do not consider ment...osterone levels may affect men,s,cognitive perform...n,s,Health Watch., All the body,s attributes chan.... Memory is the most fragile mental function. With...rocessed less carefully, and,details often slip. T...
Other Medicine Technology:Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients 2Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients 3Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients 4Testosterone May Improve Mental Function, From the Harvard Men's Health Watch 2
Glucose (Liquid) Reagent
Glucose Hexokinase Reagent Set
Glucose UV Reagent
Glucose Color Reagent
Medicine Products: